Achieve Life Sciences (ACHV) Scheduled to Post Earnings on Tuesday

Achieve Life Sciences (NASDAQ:ACHV) will post its quarterly earnings results after the market closes on Tuesday, August 13th. Analysts expect Achieve Life Sciences to post earnings of ($0.22) per share for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link.

Achieve Life Sciences (NASDAQ:ACHV) last posted its quarterly earnings data on Thursday, May 9th. The biopharmaceutical company reported ($0.26) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.24) by ($0.02). On average, analysts expect Achieve Life Sciences to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Achieve Life Sciences Stock Down 5.1 %

Shares of ACHV stock opened at $4.28 on Monday. Achieve Life Sciences has a 12 month low of $3.03 and a 12 month high of $5.98. The company’s fifty day simple moving average is $4.84 and its 200-day simple moving average is $4.69. The firm has a market cap of $146.98 million, a PE ratio of -3.32 and a beta of 1.54.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the company. Jonestrading started coverage on Achieve Life Sciences in a report on Wednesday, April 17th. They issued a “buy” rating and a $20.00 price objective for the company. Oppenheimer dropped their target price on shares of Achieve Life Sciences from $18.00 to $11.00 and set an “outperform” rating on the stock in a report on Monday, May 13th.

About Achieve Life Sciences

Achieve Life Sciences, Inc, a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms.